Conducting industrial research to develop an innovative personalized approach to prevention, diagnosis, and recommendations for the treatment of dysbiosis

The overall objective of the project is to increase Gama Consult's competitiveness and innovation capacity by developing product innovation to support accelerated technology uptake, resource efficiency and ICT approaches to personal medicine, diagnostics and individual therapy. The main objective of the planned industrial research is to develop an innovative product and service to control the balance of the microflora in the oral cavity and the gastrointestinal tract in humans and to support the treatment of various diseases (allergies, asthma, diabetes, Crohn's disease, liver diseases, ) as well as for the prevention of dysbacteriosis. The target group may be different: newborns and children up to one year, pregnant and nursing mothers, adolescents in puberty, active workers and retired people. The research program includes: - Creation of an innovative scientifically-based algorithm for the study and evaluation of the composition and quantity of the micro-organisms in the oral cavity and the intestinal tract with the possibility of its application in various medical centers in the country and in Europe; - Development of a model for an individual approach in the treatment of microbial dysbiosis; - Development of new biomarkers for early diagnosis of microbial dysbiosis using non-invasive methods of analysis of saliva, breast milk and intestinal excrement; The project's activities are related to the provision of expert staff remuneration for carrying out scientific research, purchasing the necessary consumables to ensure the development, development and testing of the product and system. As a result of the implementation of the project, it is expected that the company's sales and market share will increase as well as new markets - inside and outside the EU.

Comments